These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19091041)

  • 1. Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities.
    Whitty CJ; Chandler C; Ansah E; Leslie T; Staedke SG
    Malar J; 2008 Dec; 7 Suppl 1(Suppl 1):S7. PubMed ID: 19091041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artemisinin-based combination therapies (ACTs): best hope for malaria treatment but inaccessible to the needy!
    Mutabingwa TK
    Acta Trop; 2005 Sep; 95(3):305-15. PubMed ID: 16098946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000.
    Ogbonna A; Uneke CJ
    Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):621-7. PubMed ID: 18499204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prices and mark-ups on antimalarials: evidence from nationally representative studies in six malaria-endemic countries.
    Palafox B; Patouillard E; Tougher S; Goodman C; Hanson K; Kleinschmidt I; Torres Rueda S; Kiefer S; O'Connell K; Zinsou C; Phok S; Akulayi L; Arogundade E; Buyungo P; Mpasela F; Poyer S; Chavasse D
    Health Policy Plan; 2016 Mar; 31(2):148-60. PubMed ID: 25944705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Price subsidies increase the use of private sector ACTs: evidence from a systematic review.
    Morris A; Ward A; Moonen B; Sabot O; Cohen JM
    Health Policy Plan; 2015 Apr; 30(3):397-405. PubMed ID: 24633915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-malarial market and policy surveys in sub-Saharan Africa.
    Diap G; Amuasi J; Boakye I; Sevcsik AM; Pecoul B
    Malar J; 2010 Apr; 9 Suppl 1(Suppl 3):S1. PubMed ID: 20423536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Out with the old, in with the new: the utility of rapid diagnostic tests for malaria diagnosis in Africa.
    Drakeley C; Reyburn H
    Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):333-7. PubMed ID: 19019399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of increasing access to artemisinin combination therapy: the Cambodian experience.
    Yeung S; Van Damme W; Socheat D; White NJ; Mills A
    Malar J; 2008 May; 7():84. PubMed ID: 18492245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisinin-based combination treatment for malaria in Africa: no perfect solutions.
    Whitty CJ; Staedke SG
    Clin Infect Dis; 2005 Oct; 41(8):1087-8. PubMed ID: 16163625
    [No Abstract]   [Full Text] [Related]  

  • 11. The Affordable Medicines Facility-malaria--a success in peril.
    Talisuna AO; Adibaku S; Amojah CN; Amofah GK; Aubyn V; Dodoo A; Juma E; Jackou DH; Mkude S; Okui AP; Ramarosandratana B; Shija SJ
    Malar J; 2012 Nov; 11():370. PubMed ID: 23137141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania.
    Njau JD; Goodman CA; Kachur SP; Mulligan J; Munkondya JS; McHomvu N; Abdulla S; Bloland P; Mills A
    Malar J; 2008 Jan; 7():4. PubMed ID: 18179716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa.
    O'Boyle S; Bruxvoort KJ; Ansah EK; Burchett HED; Chandler CIR; Clarke SE; Goodman C; Mbacham W; Mbonye AK; Onwujekwe OE; Staedke SG; Wiseman VL; Whitty CJM; Hopkins H
    BMC Med; 2020 Jan; 18(1):17. PubMed ID: 31996199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artemisinins in malaria treatment in the UK.
    Drug Ther Bull; 2010 Nov; 48(11):129-32. PubMed ID: 21057033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Making antimalarial agents available in Africa.
    Arrow KJ; Gelband H; Jamison DT
    N Engl J Med; 2005 Jul; 353(4):333-5. PubMed ID: 16000348
    [No Abstract]   [Full Text] [Related]  

  • 16. Do price subsidies on artemisinin combination therapy for malaria increase household use? Evidence from a repeated cross-sectional study in remote regions of Tanzania.
    Cohen JL; Yadav P; Moucheraud C; Alphs S; Larson PS; Arkedis J; Massaga J; Sabot O
    PLoS One; 2013; 8(7):e70713. PubMed ID: 23923018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Access to subsidized ACT and malaria treatment--evidence from the first year of the AMFm program in six districts in Uganda.
    Fink G; Dickens WT; Jordan M; Cohen JL
    Health Policy Plan; 2014 Jul; 29(4):517-27. PubMed ID: 23783833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quest for universal access to effective malaria treatment: how can the AMFm contribute?
    Matowe L; Adeyi O
    Malar J; 2010 Oct; 9():274. PubMed ID: 20932286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers to prompt and effective malaria treatment among the poorest population in Kenya.
    Chuma J; Okungu V; Molyneux C
    Malar J; 2010 May; 9():144. PubMed ID: 20507555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
    Dodoo AN; Fogg C; Asiimwe A; Nartey ET; Kodua A; Tenkorang O; Ofori-Adjei D
    Malar J; 2009 Jan; 8():2. PubMed ID: 19123926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.